Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.28−0.16 (-6.45%)
Close on Nov 20, 2026Market cap $4.07MP/E –Yield –
Scienture free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Scienture's free cash flow for the twelve months ending Dec 31, 2024 was -$14.28M. For fiscal 2024 it was -$14.28M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$14.28M | – |
| FY2021 | Dec 31, 2021 | -$2.59M | – |
| FY2020 | Dec 31, 2020 | -$2.25M | – |
| FY2013 | Dec 31, 2013 | -$855.57K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$2.91M | – |
| Q4 FY2020 | Dec 31, 2020 | -$729.54K | – |
| Q3 FY2020 | Sep 30, 2020 | $2.48M | – |
See a number that looks wrong?